InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Dianthus Therapeutics, Inc.

DNTH Clue Score33
United States Fiscal year ends December CIK 0001690585 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Fairmount Funds Management LLC
29 Sep 2023
Director
Buy indirect
24,670
$13.63
$336.25K
Fairmount Funds Management LLC
26 Sep 2023
Director
Buy indirect
30,000
$13.15
$394.50K
Simrat Randhawa
22 Sep 2023
Chief Medical Officer
Buy
2,000
$13.20
$26.40K
Simrat Randhawa
21 Sep 2023
Chief Medical Officer
Buy
2,000
$13.20
$26.40K
Fairmount Funds Management LLC
19 Sep 2023
Director
Buy indirect
30,000
$13.20
$396.00K
Fairmount Funds Management LLC
13 Sep 2023
Director
Buy indirect
9,367
$11.76
$110.16K
Fairmount Funds Management LLC
12 Sep 2023
Director
Buy indirect
14,887
$10.85
$161.52K
Bruce Booth
29 Jun 2020
Director
Buy indirect
1,250,000
$8.00
$10.00M
Jason Gardner
25 Jun 2018
See Remarks
Buy
400
$15.00
$6.00K
David Scadden
25 Jun 2018
Director
Buy
6,600
$15.00
$99.00K
Show all 121 transactions →

What was left out

Form 4 filings counted 242
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 71
Sales at will 37
Transactions with no price 0
Shares from compensation/vesting 32,438,229
Sales filed before the plan box existed 37
History held since 27 Jun 2018